Precursor-directed biosynthesis and biological activity of tripropeptin Cpip, a new tripropeptin C analog containing pipecolic acid

J Antibiot (Tokyo). 2024 Apr;77(4):238-244. doi: 10.1038/s41429-024-00703-9. Epub 2024 Jan 24.

Abstract

Tripropeptin C, a non-ribosomal cyclic lipopeptide containing three proline residues, exhibits excellent efficacy in the mouse-methicillin-resistant Staphylococcus aureus septicemia model. Since tripropeptins contain L-prolyl-D-proline and, as a result, are known to form a hairpin structure in proteins, it was of interest to determine whether this substructure contributes to their antibacterial activity. In this study, prolines in tripropeptin C were replaced with pipecolic acid(s) using precursor-directed biosynthesis. Only a new tripropeptin analog, tripropeptin Cpip, which has one L-pipecolic acid in place of L-proline, was isolated. The in vitro antimicrobial activity of the new analog was approximately two to four times weaker activity against Gram-positive bacteria, including drug-resistant species, compared with that of tripropeptin C. These results suggest that the L-prolyl-D-proline substructure plays an important role in the observed potency of tripropeptins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry
  • Inositol Phosphates*
  • Lipopeptides
  • Methicillin-Resistant Staphylococcus aureus* / metabolism
  • Mice
  • Microbial Sensitivity Tests
  • Pipecolic Acids*
  • Proline
  • Prostaglandins E*

Substances

  • tripropeptin C
  • pipecolic acid
  • prostaglandin-inositol cyclic phosphate
  • Anti-Bacterial Agents
  • Lipopeptides
  • Proline
  • Inositol Phosphates
  • Pipecolic Acids
  • Prostaglandins E